On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 InfectionJean‐Michel Molina, Jean-François Delfraissy, Catherine Capitant et al.|New England Journal of Medicine|2015Cited by 1.6k
Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trialFrançois Raffi, Anton Pozniak, Abdel G. Babiker et al.|The Lancet|2014Cited by 175
Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtideBonaventura Clotet, Jonathan Schapiro, François Raffi et al.|AIDS|2004Cited by 72
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trialsChloe Orkin, Christine Katlama, Valerie Teal et al.|The Lancet HIV|2023Cited by 31